Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy.
Niccoli, Giampaolo
Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy. [electronic resource] - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Jul 2013 - 353-9 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study
1969-6213
10.4244/EIJV9I3A57 doi
Age Factors
Aged
Cardiovascular Agents--administration & dosage
Coronary Angiography
Coronary Artery Disease--diagnosis
Coronary Restenosis--epidemiology
Coronary Thrombosis--epidemiology
Drug-Eluting Stents
Everolimus
Female
Humans
Incidence
Kaplan-Meier Estimate
Logistic Models
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Percutaneous Coronary Intervention--adverse effects
Prospective Studies
Prosthesis Design
Registries
Risk Factors
Sirolimus--administration & dosage
Time Factors
Treatment Outcome
Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy. [electronic resource] - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Jul 2013 - 353-9 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study
1969-6213
10.4244/EIJV9I3A57 doi
Age Factors
Aged
Cardiovascular Agents--administration & dosage
Coronary Angiography
Coronary Artery Disease--diagnosis
Coronary Restenosis--epidemiology
Coronary Thrombosis--epidemiology
Drug-Eluting Stents
Everolimus
Female
Humans
Incidence
Kaplan-Meier Estimate
Logistic Models
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Percutaneous Coronary Intervention--adverse effects
Prospective Studies
Prosthesis Design
Registries
Risk Factors
Sirolimus--administration & dosage
Time Factors
Treatment Outcome